1. European Medicines Agency (1998) ICH topic E8 general considerations for clinical trials. Note for guidance on general considerations for clinical trials. EMEA/CPMP/ICH/291/95
2. Duff G (2006) Expert Scientific Group on phase one clinical trials final report. Stationery Office, Norwich
3. European Medicines Agency (1998) ICH guideline S6 pre-clinical safety evaluation of biotechnology-derived products. EMEA/CPMP/ICH/302/95
4. European Medicines Agency (2000) ICH guideline M3 (R1) non-clinical safety studies for the conduct of human clinical trials for pharmaceuticals. EMEA/CPMP/ICH/286/95
5. European Medicines Agency, Committee for Medicinal Products for Human Use (2007) Guideline on strategies to identify and mitigate risks for first-in-human clinical trials with investigational medicinal products. EMEA/CHMP/SWP/28367/07